Latest Duke University School of Medicine Stories
The National Foundation for Infectious Diseases (NFID) has selected F.
Major new precision medicine initiative takes root in Singapore SINGAPORE and LOS ANGELES, Feb. 10, 2014 /PRNewswire/ -- ImaginAb, Inc.
A Phase 1b clinical trial to evaluate Celgosivir as a treatment against Dengue Fever has opened for enrolment at the Singapore General Hospital.
Transcript Available Now, Video to be Available at WWW.USNEWS.COM New York (PRWEB) November 07, 2011 Mount Sinai
MILFORD, Mass., May 11, 2011 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today welcomed into its Centers of Innovation Program the Proteomics Core Facility at the Duke University School of Medicine (Durham, NC). In a ceremony at Duke University, Waters recognized Associate Research Prof. M.
The Grizzard Communications Group, an industry leader in integrated, direct response marketing and fundraising, today announced it has been selected to serve as agency of record for Duke Medicine's Grateful Patient fundraising initiative.
- The act of sweetening by admixture of some saccharine substance.